Skip to content

Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1551-1561
Number of pages11
JournalBlood Advances
Volume2
Issue number13
Early online date3 Jul 2018
DOIs
DateSubmitted - 22 Nov 2017
DateAccepted/In press - 24 May 2018
DateE-pub ahead of print - 3 Jul 2018
DatePublished (current) - 10 Jul 2018

Abstract

CD38 is a transmembrane exoenzyme that is associated with poor prognosis in chronic lymphocytic leukemia (CLL). High CD38 levels in CLL cells are linked to increased cell migration, but the molecular basis is unknown. CD38 produces nicotinic acid adenine dinucleotide phosphate and adenosine 5′-diphosphate-ribose, both of which can act to increase intracellular Ca2+ levels. Here we show that CD38 expression increases basal intracellular Ca2+ levels and stimulates CLL cell migration both with and without chemokine stimulation. We find that CD38 acts via intracellular Ca2+ to increase the activity of the Ras family GTPase Rap1, which is in turn regulated by the Ca2+-sensitive Rap1 guanine-nucleotide exchange factor RasGRP2. Both Rap1 and RasGRP2 are required for CLL cell migration, and RasGRP2 is polarized in primary CLL cells with high CD38 levels. These results indicate that CD38 promotes RasGRP2/Rap1-mediated CLL cell adhesion and migration by increasing intracellular Ca2+ levels.

Download statistics

No data available

Documents

Documents

  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via ASH at http://www.bloodadvances.org/content/2/13/1551 . Please refer to any applicable terms of use of the publisher.

    Final published version, 1 MB, PDF document

DOI

View research connections

Related faculties, schools or groups